dulaglutide and semaglutide versus once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial Dulaglutide vs semaglutide: Which is

Genetics should not replace medical judgment, but it can help inform the conversation

The SURMOUNT-1 trial found participants lost up to 22.5% of their body weight over 72 weeks, one of the most impressive results to date

GLP-1 receptor agonists are not controlled substances under Florida or federal law, so the prescribing process is straightforward and PlexusDx Weight Management Protocols ship to all Florida zip codes via async intake

For instance, an overweight individual may find that 1.21.5 g/kg (using actual body weight) is sufficient for muscle maintenance

This framework helps contextualize what to expect during your treatment journey and when to reassess with your provider

M.et al (1998)